Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma

NCT01711177 is registered in ClinicalTrials.gov with Université de Montréal as lead sponsor.

NCT NCT01711177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01711177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma
Lead sponsor
Université de Montréal
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2012
Completion date
March 31, 2013
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma